A competitive Co-cultivation assay for cancer drug specificity evaluation

Journal of Biomolecular Screening

Volumn 16, Issue 8, 2011, Pages 818-824

  El Debs, Bachir W ^a,b   Tschulena, Ulrich ^c   Griffiths, Andrew D ^a,b   Merten, Christoph A ^a,b,d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ LOUIS PASTEUR   (France)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Anticancer drugs; Cell based assays; Competitive co cultivation; High throughput screening; Indirect inhibition assays

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; PLX 4720; SODIUM AZIDE; TYRPHOSTIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL ASSAY; CELL KILLING; CELL STRAIN HEK293; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG SCREENING; DRUG SPECIFICITY; EMBRYO; FLUORESCENCE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; FLUORESCENCE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INDOLES; KIDNEY NEOPLASMS; ORGAN SPECIFICITY; REPRODUCIBILITY OF RESULTS; SODIUM AZIDE; SULFONAMIDES; TYRPHOSTINS;

EID: 80054759794     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111414898     Document Type: Article

References (17)

1. World health Organization. http://www.who.int/cancer/en/. Accessed April 26, 2011.
2. Shapiro, C. L.; Recht, A. Side Effects of Adjuvant Treatment of Breast Cancer. N. Engl. J. Med. 2001, 26, 1997-2008. (Pubitemid 32568155)
3. Yeh, T. H. Cardiotoxicity Induced by Chemotherapy and Antibody Therapy. Annu. Rev. Med. 2006, 57, 485-498.
4. Lauer-Fields, J. L.; Minond, D.; Chase, P. S.; Chen, X.; Baillargeon, P. E.; Saldanha, R.; Stawikowska, R.; Hodder, P.; Fields, G. B. High Throughput Screening of Potentially Selective MMP-13 Exosite Inhibitors Utilizing a Triple-Helical FRET Substrate. Bioorg. Med. Chem. 2009, 17(3), 990-1005.
5. Card, A.; Caldwell, C.; Min, H.; Lokchander, B.; Hualin, X.; Sciabola, S.; Kamath, A. V.; Clugston, S. L.; Tschantz, W. R.; Wang, L.; et al. High-Throughput Biochemical Kinase Selectivity Assays: Panel Development and Screening Applications. J. Biomol. Screen. 2009, 14(1), 31-42.
6. Lin, J. H.; Lu, A. Y. H. Role of Pharmacokinetics and Metabolism in Drug Discovery and Development. Pharmacol. Rev. 1997, 49(4), 403-449. (Pubitemid 28030947)
7. Thierbach, R.; Steinberg, P. Automated Soft Agar Assay for the High-Throughput Screening of Anticancer Compounds. Anal. Biochem. 2009, 387, 318-320.
8. Yip, K. W.; Mao, X.; Au, P. Y.; Hedley, D. W.; Chow, S.; Dalili, S.; Mocanu, J. D.; Bastianutto, C.; Schimmer, A.; Liu, F. F. Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen. Clin. Cancer Res. 2006, 12(18), 5557-5569. (Pubitemid 44497274)
9. Granieri, L.; Miller, O. J.; Griffiths, A. D.; Merten, C. A. A Competition-Based Assay for the Screening of Species-Specific Antibiotics. J. Antimicrob. Chemother. 2009, 64(1), 62-68.
10. Clausell-Tormos, J.; Griffiths, A. D.; Merten, C. A. Coupling the Inhibition of Viral Transduction with a Positive Fluorescence Signal. Comb. Chem. High Throughput Screen. 2010, 13, 352-357.
11. Zhang, J. H.; Chung, T. D.; Oldenburg, K. R. A Simple Statistical Parameter for Use in Evaluation and Validation of High-Throughput Screening Assay. J. Biomol. Screen. 1999, 4, 67-73. (Pubitemid 29278954)
12. Levitzki, A.; Mishani, E. Tyrphostins and Other Tyrosine Kinase Inhibitors. Annu. Rev. Biochem. 2006, 75, 93-109. (Pubitemid 44118027)
13. Hanks, S. K.; Quinn, A. M.; Hunter, T. The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains. Science 1988, 241, 42-52.
14. Zhang, Y. G.; Du, Q.; Fang, W. G.; Jin, M. L.; Tian, X. X. Tyrphostin AG1478 Suppresses Proliferation and Invasion of Human Breast Cancer Cells. Int. J. Oncol. 2008, 33, 595-602.
15. Johns, T. G.; Luwor, R. B.; Murone, C.; Walker, F.; Weinstock, J.; Vitali, A. A.; Perera, R. M.; Jungbluth, A. A.; Stockert, E.; Old, L. J.; et al. Antitumor Efficacy of Cytotoxic Drugs and the Monoclonal Antibody 806 Is Enhanced by the EGF Receptor Inhibitor AG1478. Proc. Natl. Acad. Sci. USA 2003, 100(26), 15871-15876. (Pubitemid 38021082)
16. Tsai, J.; Lee, J. T.; Wang, W.; Zhang, J.; Cho, H.; Mamo, S.; Bremer, R.; Gillette, S.; Kong, J.; Haass, N. K.; et al. Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase with Potent Antimelanoma Activity. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(8), 3041-3046. (Pubitemid 351723664)
17. Nathanson, K. L. Using Genetics and Genomics Strategies to Personalize Therapy for Cancer: Focus on Melanoma. Biochem. Pharmacol. 2010, 80(5), 755-761.